BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2120494)

  • 1. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration.
    Yamamura M; Kinoshita K; Nakagawa H; Tanaka T; Maeda K; Ishida R
    Jpn J Pharmacol; 1990 Aug; 53(4):451-61. PubMed ID: 2120494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs.
    Breese GR; Cott JM; Cooper BR; Prange AJ; Lipton MA; Plotnikoff NP
    J Pharmacol Exp Ther; 1975 Apr; 193(1):11-22. PubMed ID: 805836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety.
    Suzuki M; Sugano H; Matsumoto K; Yamamura M; Ishida R
    J Med Chem; 1990 Aug; 33(8):2130-7. PubMed ID: 2115588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new TRH analogue, YM-14673 on the central nervous system.
    Yamamoto M; Shimizu M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):561-5. PubMed ID: 3125485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of thyrotropin releasing hormone (TRH) on drug-induced narcosis and hypothermia in rabbits.
    Horita A; Carino MA; Chesnut RM
    Psychopharmacology (Berl); 1976 Aug; 49(1):57-62. PubMed ID: 822448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of thyrotropin releasing hormone on pentobarbital tolerance.
    Bhargava HN
    Eur J Pharmacol; 1981 Jun; 72(1):63-8. PubMed ID: 6790297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogs containing a 1-substituted 2-oxoimidazolidine moiety.
    Maeda H; Suzuki M; Sugano H; Yamamura M; Ishida R
    Int J Pept Protein Res; 1989 Jun; 33(6):403-11. PubMed ID: 2506142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system.
    Miyamoto M; Fukuda N; Narumi S; Nagai Y; Saji Y; Nagawa Y
    Life Sci; 1981 Feb; 28(8):861-9. PubMed ID: 6783804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
    Yamamura M; Suzuki M; Matsumoto K
    Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new analogue of thyrotropin-releasing hormone on pentobarbital-induced sleeping time in rodents.
    Yamamoto M; Shimizu M
    Neuropharmacology; 1989 Aug; 28(8):863-6. PubMed ID: 2506487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (III): Inhibition of pentobarbital anesthesia.
    Yamamura M; Kinoshita K; Nakagawa H; Ishida R
    Jpn J Pharmacol; 1991 Jan; 55(1):69-80. PubMed ID: 1904115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats.
    Kinoshita K; Nagao T; Ono H
    Neuropharmacology; 1994 Oct; 33(10):1183-8. PubMed ID: 7862253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone (TRH)-induced hyperthermia and behavioral excitation in rabbits.
    Horita A; Carino MA
    Psychopharmacol Commun; 1975; 1(4):403-14. PubMed ID: 817376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRH and its novel analog (DN-1417): antipentobarbital action and involvement of cholinergic mechanisms.
    Miyamoto M; Nagai Y; Narumi S; Saji Y; Nagawa Y
    Pharmacol Biochem Behav; 1982 Oct; 17(4):797-806. PubMed ID: 6817348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological evaluation of RX 77368--a stabilised analogue of thyrotropin-releasing hormone (TRH).
    Metcalf G; Dettmar PW; Fortune D; Lynn AG; Tulloch IF
    Regul Pept; 1982 Mar; 3(3-4):193-206. PubMed ID: 6805044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TRH on the central nervous system of the rabbit.
    Horita A; Carino MA; Smith JR
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):111-6. PubMed ID: 138141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
    Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
    Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.